Galena Biopharma (GALE) disclosed in a regulatory filing that it agreed to issue 3,125,000 shares of common stock to five parties to settle outstanding claims in a "certain matter." In addition, it settled a securities class action lawsuit for $20M, $16.7M of which was paid by the company's insurance carriers and $2.3M in cash paid by the company on July 1. On July 6, it issued 480,053 shares of common stock pursuant to the court order.